Serious infections related to treatment with rituximab in patients with multiple sclerosis are rare and successfully resolvable.
All articles by Natasha Dyal, MD
-
Latest News Your top articles for Monday
For More Personalized News -
Haymarket Medical NetworkTop Picks
- Loading...
Continuing Medical Education (CME/CE) Courses